StockData
Prothena Corp Public Ltd Co logo

Prothena Corp Public Ltd Co (PRTA) stock

PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3022% below fair value
$8.26+0.29 (+3.64%)

Close on Nov 17, 2026Market cap $424.04MP/E –Yield –

Prothena Corp Public operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Prothena Corp Public's operating income for the twelve months ending Jun 30, 2026 was -$55.51M. For fiscal 2025 it was -$214.64M. The highest annual figure on record is $71.98M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$214.64M–
FY2024Dec 31, 2024-$154.56M–
FY2023Dec 31, 2023-$191.04M–
FY2022Dec 31, 2022-$131.56M-282.8%
FY2021Dec 31, 2021$71.98M–
FY2020Dec 31, 2020-$112.73M–
FY2019Dec 31, 2019-$85.70M–
FY2018Dec 31, 2018-$158.86M–
FY2017Dec 31, 2017-$155.25M–
FY2016Dec 31, 2016-$159.54M–
FY2015Dec 31, 2015-$79.94M–
FY2014Dec 31, 2014-$6.65M–
FY2013Dec 31, 2013-$40.43M–
FY2012Dec 31, 2012-$41.41M–
FY2011Dec 31, 2011-$29.24M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$21.10M–
Q1 FY2026Mar 31, 2026$30.04M–
Q4 FY2025Dec 31, 2025-$24.20M–
Q3 FY2025Sep 30, 2025-$40.24M–
Q2 FY2025Jun 30, 2025-$84.62M-244.9%
Q1 FY2025Mar 31, 2025-$65.58M–
Q4 FY2024Dec 31, 2024-$64.90M–
Q3 FY2024Sep 30, 2024-$66.51M-745.3%
Q2 FY2024Jun 30, 2024$58.38M–
Q1 FY2024Mar 31, 2024-$81.53M–
Q4 FY2023Dec 31, 2023-$78.52M–
Q3 FY2023Sep 30, 2023$10.31M–
Q2 FY2023Jun 30, 2023-$66.50M–
Q1 FY2023Mar 31, 2023-$56.33M–
Q4 FY2022Dec 31, 2022-$72.00K–
Q3 FY2022Sep 30, 2022-$50.33M-146.1%
Q2 FY2022Jun 30, 2022-$43.21M-254.6%
Q1 FY2022Mar 31, 2022-$37.94M–
Q4 FY2021Dec 31, 2021-$33.09M–
Q3 FY2021Sep 30, 2021$109.23M–
Q2 FY2021Jun 30, 2021$27.95M–
Q1 FY2021Mar 31, 2021-$32.11M–
Q4 FY2020Dec 31, 2020-$30.31M–
Q3 FY2020Sep 30, 2020-$30.85M–
Q2 FY2020Jun 30, 2020-$26.73M–
Q1 FY2020Mar 31, 2020-$24.85M–
Q4 FY2019Dec 31, 2019-$23.27M–
Q3 FY2019Sep 30, 2019-$20.97M–
Q2 FY2019Jun 30, 2019-$18.50M–
Q1 FY2019Mar 31, 2019-$22.95M–
Q4 FY2018Dec 31, 2018-$22.76M–
Q3 FY2018Sep 30, 2018-$24.32M–
Q2 FY2018Jun 30, 2018-$63.07M–
Q1 FY2018Mar 31, 2018-$48.71M–
Q4 FY2017Dec 31, 2017-$47.32M–
Q3 FY2017Sep 30, 2017-$53.53M–
Q2 FY2017Jun 30, 2017-$18.13M–
Q1 FY2017Mar 31, 2017-$36.27M–
Q4 FY2016Dec 31, 2016-$49.28M–
Q3 FY2016Sep 30, 2016-$42.69M–

More Prothena Corp Public figures

See a number that looks wrong?